-
1دورية أكاديمية
المؤلفون: Mussetti, Alberto, Salas, Maria Queralt, Condom, Maria, Antonio, Maite, Ochoa, Cristian, Ivan, Iulia, Jimenez Ruiz-De la Torre, David, Sanz Linares, Gabriela, Ansoleaga, Belen, Patiño-Gutierrez, Beatriz, Jimenez-Prat, Laura, Parody, Rocio, Sureda-Balari, Ana
المصدر: JMIR Formative Research, Vol 5, Iss 3, p e26121 (2021)
مصطلحات موضوعية: Medicine
الوصف: BackgroundPatients who have recently received a hematopoietic cell transplant (HCT) are at higher risk of acute complications in the first weeks after discharge, especially during the COVID-19 pandemic. ObjectiveThe aim of this study was to test the use of a telehealth platform for the follow-up of HCT patients during the first two weeks after discharge. MethodsIn total, 21 patients who received autologous or allogeneic HCT for hematological malignancies were screened from April 30, 2020, to July 15, 2020. The telehealth platform assisted in the daily collection of vital signs as well as physical and psychological symptoms for two weeks after hospital discharge. The required medical devices (oximeter and blood pressure monitor) were given to patients and a dedicated smartphone app was developed to collect this data. The data were reviewed daily through web-based software by a hematologist specializing in HCT. ResultsOnly 12 of 21 patients were able to join and complete the study. Technological barriers were the most frequent limiting factor in this study. Among the 12 patients who completed the study, adherence to data reporting was high. The patients’ experience of using such a system was considered good. In two cases, the system enabled the early recognition of acute complications. ConclusionsThis pilot study showed that telehealth systems can be applied in the early posttransplant setting, with evident advantages for physicians and patients for both medical and psychological aspects. Technological issues still represent a challenge for the applicability of such a system, especially for older adult patients. Easier-to-use technologies could help to expand the use of telehealth systems in this setting in the future.
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Mercadal, SantiagoAff1, Aff2, IDs00277024056770_cor1, Mussetti, Alberto, Lee, Catherine J., Arevalo, Carolina, Odstrcil, Silvina M., Peña, Esteban, Sureda, Anna, Couriel, Daniel R.Aff1, Aff2
المصدر: Annals of Hematology. 103(5):1717-1727
-
3دورية أكاديمية
المؤلفون: Wieduwilt, MJ, Metheny, L, Zhang, MJ, Wang, HL, Estrada-Merly, N, Marks, DI, Al-Homsi, AS, Muffly, L, Chao, N, Rizzieri, D, Gale, RP, Gadalla, SM, Cairo, M, Mussetti, A, Gore, S, Bhatt, VR, Patel, SS, Michelis, FV, Inamoto, Y, Badawy, SM, Copelan, E, Palmisiano, N, Kharfan-Dabaja, MA, Lazarus, HM, Ganguly, S, Bredeson, C, Perez, MAD, Cassaday, R, Savani, BN, Ballen, K, Martino, R, Wirk, B, Bacher, U, Aljurf, M, Bashey, A, Murthy, HS, Yared, JA, Aldoss, I, Farhadfar, N, Liu, HT, Abdel-Azim, H, Waller, EK, Solh, M, Seftel, MD, van der Poel, M, Grunwald, MR, Liesveld, JL, Kamble, RT, McGuirk, J, Munker, R, Cahn, JY, Lee, JW, Freytes, CO, Krem, MM, Winestone, LE, Gergis, U, Nathan, S, Olsson, RF, Verdonck, LF, Sharma, A, Ringden, O, Friend, BD, Cerny, J, Choe, H, Chhabra, S, Nishihori, T, Seo, S, George, B, Baxter-Lowe, LA, Hildebrandt, GC, de Lima, M, Litzow, M, Kebriaei, P, Hourigan, CS, Abid, MB, Weisdorf, DJ, Saber, W
المصدر: Blood advances. 6(1):339-357
مصطلحات موضوعية: Medicin och hälsovetenskap
-
4دورية أكاديمية
المؤلفون: Nabergoj, MitjaAff1, IDs4140902302193z_cor1, Eikema, Diderik-Jan, Koster, Linda, Platzbecker, Uwe, Sockel, Katja, Finke, Jürgen, Kröger, Nicolaus, Forcade, Edouard, Nagler, Arnon, Eder, Matthias, Tischer, Johanna, Broers, Annoek E. C., Kuball, Jürgen, Wilson, Keith M. O., Hunault-Berger, Mathilde, Collin, Matthew, Russo, Domenico, Corral, Lucía López, Helbig, Grzegorz, Mussetti, Alberto, Scheid, Christof, Gurnari, CarmeloAff22, Aff23, Raj, Kavita, Drozd-Sokolowska, Joanna, Yakoub-Agha, Ibrahim, Robin, Marie, McLornan, Donal P.
المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 59(3):395-402
-
5دورية أكاديمية
المؤلفون: Mussetti, A.Aff1, IDs41409023021475_cor1, Rius-Sansalvador, B.Aff2, Aff3, Moreno, V.Aff2, Aff3, Peczynski, C., Polge, E., Galimard, J. E., Kröger, N., Blaise, D., Peffault de Latour, R.Aff9, Aff10, Kulagin, A., Mousavi, A., Stelljes, M., Hamladji, R. M., Middeke, J. M., Salmenniemi, U., Sengeloev, H., Forcade, E., Platzbecker, U., Reményi, P., Angelucci, E., Chevallier, P., Yakoub-Agha, I., Craddock, C., Ciceri, F., Schroeder, T., Aljurf, M., Ch, Koenecke, Moiseev, I., Penack, O., Schoemans, H.Aff31, Aff32, Mohty, M., Glass, B., Sureda, A., Basak, G., Peric, Z.
المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 59(2):232-238
-
6دورية أكاديمية
المؤلفون: Jimenez, AMJ, De Lima, M, Komanduri, KV, Wang, TP, Zhang, MJ, Chen, KR, Abdel-Azim, H, Abid, MB, Aljurf, M, Alkhateeb, H, Assal, A, Bacher, U, Baron, F, Battiwalla, M, Beitinjaneh, A, Bejanyan, N, Bhatt, VR, Byrne, M, Cahn, JY, Cairo, M, Castillo, P, Copelan, E, DeFilipp, Z, Perez, MAD, Elsawy, M, Gale, RP, George, B, Grunwald, MR, Hildebrandt, GC, Hogan, WJ, Kanakry, CG, Kansagra, A, Kharfan-Dabaja, MA, Khera, N, Krem, MM, Lazaryan, A, Maakaron, J, Martino, R, McGuirk, J, Michelis, FV, Milone, G, Mishra, A, Murthy, HS, Mussetti, A, Nathan, S, Nishihori, T, Olsson, RF, Palmisiano, N, Patel, S, Saad, A, Seo, S, Sharma, A, Solh, M, Verdonck, LF, Wirk, B, Yared, JA, Litzow, M, Kebriaei, P, Hourigan, CS, Saber, W, Weisdorf, D
المصدر: Bone marrow transplantation. 56(12):3068-3077
مصطلحات موضوعية: Medicin och hälsovetenskap
-
7دورية أكاديمية
المؤلفون: Peña, M.Aff1, Aff2, Montané, C.Aff1, Aff2, Paviglianiti, A.Aff1, Aff2, Hurtado, L., González, S., Carro, I.Aff1, Aff2, Maluquer, C.Aff1, Aff2, Domingo-Domenech, E.Aff1, Aff2, Gonzalez-Barca, E.Aff1, Aff2, Aff3, Sureda, A.Aff1, Aff2, Aff3, Mussetti, A.Aff1, Aff2, IDs41409023020692_cor11
المصدر: Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 58(11):1282-1285
-
8دورية أكاديمية
المؤلفون: Ahmed, S, Ghosh, N, Ahn, KW, Khanal, M, Litovich, C, Mussetti, A, Chhabra, S, Cairo, M, Mei, M, William, B, Nathan, S, Bejanyan, N, Olsson, RF, Dahi, PB, van der Poel, M, Steinberg, A, Kanakry, J, Cerny, J, Farooq, U, Seo, S, Kharfan-Dabaja, MA, Sureda, A, Fenske, TS, Hamadani, M
المصدر: British journal of haematology. 190(4):573-582
مصطلحات موضوعية: Medicin och hälsovetenskap
-
9دورية أكاديمية
المؤلفون: Jagadeesh, D, Majhail, NS, He, YZ, Ahn, KW, Litovich, C, Ahmed, S, Aljurf, M, Bacher, U, Badawy, SM, Bejanyan, N, Cairo, M, Cerny, J, Epperla, N, Farhadfar, N, Freytes, CO, Gale, RP, Haverkos, B, Hossain, N, Inwards, D, Kamble, RT, Kenkre, VP, Lazarus, HM, Lazaryan, A, Lekakis, L, Mei, MH, Murthy, HS, Mussetti, A, Nathan, S, Nishihori, T, Olsson, RF, Geethakumari, PR, Savani, BN, Yared, JA, Fenske, TS, Kharfan-Dabaja, MA, Sureda, A, Hamadani, M
المصدر: Cancer. 126(10):2279-2287
مصطلحات موضوعية: Medicin och hälsovetenskap
-
10دورية أكاديمية
المؤلفون: Lidia Hurtado, Melinda Gonzalez Concepcion, Aida Flix-Valle, Marina Ruiz-Romeo, Sonia Gonzalez-Rodriguez, Marta Peña, Annalisa Paviglianiti, Maria Angeles Pera Jambrina, Anna Sureda, Cristian Ochoa-Arnedo, Alberto Mussetti
المصدر: JMIR Formative Research, Vol 8, p e55918 (2024)
مصطلحات موضوعية: Medicine
الوصف: BackgroundPatients with hematological malignancies receiving hematopoietic cell transplantation (HCT) or chimeric antigen receptor (CAR) T-cell therapy are at risk of developing serious clinical complications after discharge. ObjectiveThe aim of the TEL-HEMATO study was to improve our telehealth platform for the follow-up of patients undergoing HCT or CAR T-cell therapy during the first 3 months after discharge with the addition of wearable devices. MethodsEleven patients who received autologous (n=2) or allogeneic (n=5) HCT or CAR T-cell therapy (n=4) for hematological malignancies were screened from November 2022 to July 2023. Two patients discontinued the study after enrollment. The telehealth platform consisted of the daily collection of vital signs, physical symptoms, and quality of life assessment up to 3 months after hospital discharge. Each patient received a clinically validated smartwatch (ScanWatch) and a digital thermometer, and a dedicated smartphone app was used to collect these data. Daily revision of the data was performed through a web-based platform by a hematologist or a nurse specialized in HCT and CAR T-cell therapy. ResultsVital signs measured through ScanWatch were successfully collected with medium/high adherence: heart rate was recorded in 8/9 (89%) patients, oxygen saturation and daily steps were recorded in 9/9 (100%) patients, and sleeping hours were recorded in 7/9 (78%) patients. However, temperature recorded manually by the patients was associated with lower compliance, which was recorded in 5/9 (55%) patients. Overall, 5/9 (55%) patients reported clinical symptoms in the app. Quality of life assessment was completed by 8/9 (89%) patients at study enrollment, which decreased to 3/9 (33%) at the end of the third month. Usability was considered acceptable through ratings provided on the System Usability Scale. However, technological issues were reported by the patients. ConclusionsWhile the addition of wearable devices to a telehealth clinical platform could have potentially synergic benefits for HCT and CAR T-cell therapy patient monitoring, noncomplete automation of the platform and the absence of a dedicated telemedicine team still represent major limitations to be overcome. This is especially true in our real-life setting where the target population generally comprises patients of older age with a low digital education level.
وصف الملف: electronic resource